Last updated on February 2019

A Study Comparing the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Chronic Cluster Headache (CCH)


Brief description of study

The purpose of the current study is to evaluate the efficacy and safety of TEV-48125 (Fremanezumab), in the prevention of CCH in adult patients.

Clinical Study Identifier: NCT02964338

Contact Investigators or Research Sites near you

Start Over

Teva Investigational Site 13811

Santa Monica, CA United States

Teva Investigational Site 13823

Stanford, CA United States

Teva Investigational Site 13837

Aurora, CO United States

Teva Investigational Site 13814

Colorado Springs, CO United States

Teva Investigational Site 13836

Denver, CO United States

Teva Investigational Site 13813

Englewood, CO United States

Teva Investigational Site 13821

New Haven, CT United States

Teva Investigational Site 13812

Stamford, CT United States

Teva Investigational Site 13810

Gainesville, FL United States

Teva Investigational Site 13829

Ormond Beach, FL United States

Teva Investigational Site 13830

Saint Petersburg, FL United States

Teva Investigational Site 34222

Augusta, GA United States

Teva Investigational Site 13833

Columbus, GA United States

Teva Investigational Site 13838

Savannah, GA United States

Teva Investigational Site 13826

Chicago, IL United States

Teva Investigational Site 13818

Ann Arbor, MI United States

Teva Investigational Site 13832

Las Vegas, NV United States

Teva Investigational Site 13831

Lebanon, NH United States

Teva Investigational Site 13820

Princeton, NJ United States

Teva Investigational Site 13827

Albuquerque, NM United States

Teva Investigational Site 13816

Amherst, NY United States

Teva Investigational Site 13817

New York, NY United States

Teva Investigational Site 13809

Raleigh, NC United States

Teva Investigational Site 13839

Salisbury, NC United States

Teva Investigational Site 13825

Cleveland, OH United States

Teva Investigational Site 13824

Philadelphia, PA United States

Teva Investigational Site 13822

Virginia Beach, VA United States

Teva Investigational Site 78120

Auchenflower, Australia

Teva Investigational Site 78118

Clayton, Australia

Teva Investigational Site 78122

Parkville, Australia

Teva Investigational Site 78121

Randwick, Australia

Teva Investigational Site 32661

Konigstein im Taunus, Germany

Teva Investigational Site 38118

Leiden, Netherlands

Teva Investigational Site 38119

Nijmegen, Netherlands

Teva Investigational Site 38117

Zwolle, Netherlands

Teva Investigational Site 34224

Glasgow, United Kingdom

Teva Investigational Site 34220

London, United Kingdom

Teva Investigational Site 34223

London, United Kingdom

Teva Investigational Site 34221

Oxford, United Kingdom

Teva Investigational Site 13819

Canoga Park, CA United States

Teva Investigational Site 13840

Tampa, FL United States

Teva Investigational Site 13841

Richmond, TX United States

Teva Investigational Site 78123

Melbourne, Australia

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.